The tariff classification of Pioglitazone Hydrochloride (CAS-112529-15-4), Vancomycin Hydrochloride (CAS-1404-93-9), and Rabeprazole (CAS-117976-89-3), all imported in bulk form, from Spain and China
Issued September 14, 2006 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 2941.90.3000, 2933.39.4100, 2934.10.1000
Product description
The first product, Pioglitazone Hydrochloride, is an orally administered antidiabetic drug. The second product, Vancomycin Hydrochloride, is a glycopeptide antibiotic produced by Streptomyces orientalis. It is indicated for use as an antibacterial drug. The third product, Rabeprazole, is indicated for the short-term treatment of, among other things, gastroesophageal reflux disease (GERD), gastric ulcer, and duodenal ulcer.
CBP rationale
The applicable subheading for Pioglitazone Hydrochloride, imported in bulk form, will be 2934.10.1000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure: Aromatic or modified aromatic: Products described in additional U. The applicable subheading for Vancomycin Hydrochloride, imported in bulk form, will be 2941.90.3000, HTSUS, which provides for “Antibiotics: Other: Other: Aromatic or modified aromatic. The applicable subheading for Rabeprazole, imported in bulk form, will be 2933.39.4100, HTSUS, which provides for “Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: Other: Other: Drugs: Other.
Full text
NY M86356 September 14, 2006 CLA-2-29:RR:NC:2:238 M86356 CATEGORY: Classification TARIFF NO.: 2934.10.1000; 2941.90.3000; 2933.39.4100 Ms. Inge Forstenzer Ren-Pharm International, Ltd. 350 Jericho Turnpike, Suite 204 Jericho, NY 11753 RE: The tariff classification of Pioglitazone Hydrochloride (CAS-112529-15-4), Vancomycin Hydrochloride (CAS-1404-93-9), and Rabeprazole (CAS-117976-89-3), all imported in bulk form, from Spain and China Dear Ms. Forstenzer: In your letter dated August 30, 2006, you requested a tariff classification ruling. The first product, Pioglitazone Hydrochloride, is an orally administered antidiabetic drug. The second product, Vancomycin Hydrochloride, is a glycopeptide antibiotic produced by Streptomyces orientalis. It is indicated for use as an antibacterial drug. The third product, Rabeprazole, is indicated for the short-term treatment of, among other things, gastroesophageal reflux disease (GERD), gastric ulcer, and duodenal ulcer. The applicable subheading for Pioglitazone Hydrochloride, imported in bulk form, will be 2934.10.1000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure: Aromatic or modified aromatic: Products described in additional U.S. note 3 to section VI.” Pursuant to General Note 13, HTSUS, the rate of duty will be free. The applicable subheading for Vancomycin Hydrochloride, imported in bulk form, will be 2941.90.3000, HTSUS, which provides for “Antibiotics: Other: Other: Aromatic or modified aromatic.” The rate of duty will be free. The applicable subheading for Rabeprazole, imported in bulk form, will be 2933.39.4100, HTSUS, which provides for “Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: Other: Other: Drugs: Other.” Pursuant to General Note 13, HTSUS, the rate of duty will be free. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033. Sincerely, Robert B. Swierupski Director, National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Roflumilast (CAS No. 162401-32-3), imported in bulk form, from Mexico
The tariff classification of Vilanterol Trifenatate (CAS No. 503070-58-4) in bulk powder form and Umeclidinium Bromide (CAS No. 869113-09-7) in bulk powder form, from India
The tariff classification of Omeprazole (CAS No. 73590-58-6) in bulk powder form, from Croatia
The tariff classification of Dalbavancin Hydrochloride (CAS No. 2227366-51-8) in bulk powder form, from Taiwan
The tariff classification of Revefenacin (CAS No. 864750-70-9) in bulk form, from France
The tariff classification of Dalbavancin Hydrochloride (CAS No. 2227366-51-8) in bulk crystal form, from Taiwan
The tariff classification of Dalbavancin Hydrochloride (CAS No. 2227366-51-8) in bulk powder form, from Italy
The tariff classification of Maropitant Citrate Monohydrate (CAS No. 359875-09-5) in bulk power form, from Italy
The tariff classification of Maropitant (CAS No. 147116-67-4) in bulk powder form, from Italy
The tariff classification of Difelikefalin Acetate (CAS No. 1024829-44-4) in bulk form, from Taiwan
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →